Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
about
Surveillance systems and methods for monitoring the post-marketing safety of influenza vaccines at the Centers for Disease Control and Prevention.Surveillance of Adverse Events After Seasonal Influenza Vaccination in Pregnant Women and Their Infants in the Vaccine Adverse Event Reporting System, July 2010-May 2016.Adverse events following quadrivalent meningococcal CRM-conjugate vaccine (Menveo®) reported to the Vaccine Adverse Event Reporting system (VAERS), 2010-2015.Post-Marketing Surveillance of Human Rabies Diploid Cell Vaccine (Imovax) in the Vaccine Adverse Event Reporting System (VAERS) in the United States, 1990‒2015.Post-licensure surveillance of quadrivalent inactivated influenza (IIV4) vaccine in the United States, Vaccine Adverse Event Reporting System (VAERS), July 1, 2013-May 31, 2015Adverse events following immunization: real causality and myths.Innovative Digital Tools and Surveillance Systems for the Timely Detection of Adverse Events at the Point of Care: A Proof-of-Concept Study.Value of an in-depth analysis of unpublished data on the safety of influenza vaccines in pregnant women.Current safety issues with quadrivalent meningococcal conjugate vaccines.The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: A Vaccine Safety Datalink study.Sudden-Onset Sensorineural Hearing Loss after Immunization: A Case-Centered Analysis.Notes from the Field: Errors in Administration of an Excess Dosage of Yellow Fever Vaccine - United States, 2017.Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).Major Birth Defects after Vaccination Reported to the Vaccine Adverse Event Reporting System (VAERS), 1990 to 2014.Assessment of Quadrivalent Human Papillomavirus Vaccine Safety Using the Self-Controlled Tree-Temporal Scan Statistic Signal-Detection Method in the Sentinel System.Characterization of the Differential Adverse Event Rates by Race/Ethnicity Groups for HPV Vaccine by Integrating Data From Different Sources.Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices.Adverse events after vaccination among HIV-positive persons, 1990-2016.
P2860
Q30249793-67156C7A-E121-4308-BF18-B5EF89172A98Q30396594-546A5619-0F2B-4A04-B6E2-D623E648BA3FQ33168344-E63F0372-9CE0-43F5-B077-C016E60D0F85Q36075411-3FDA6BE3-3358-4E51-BE6A-9926671FC7A1Q37027049-B6C461EF-469C-4500-8021-7D66F265431CQ38778111-D51F3549-8454-419D-A0FB-9411EC4BE7A9Q39650695-D24C33E5-978E-4737-8BFD-2EA65BEAE5F2Q42675359-6E1105EC-5D9B-41D6-A776-F5469B114ECFQ43168629-D342F176-3637-49D0-BAFF-F4535A0A2F2BQ46081672-871057A4-7368-4577-94E0-1766C3306DF0Q46136404-4BF358C0-5721-4C3D-8941-A1BDD1DF6407Q49693503-B1B56977-AFDB-448A-8A68-5DF67407834FQ52558356-BCCD41FC-137A-4D65-9DB3-86C3C6702B6AQ54407474-EA905531-5E28-4567-BECF-2C262B1C9E3EQ54938964-020CB164-60B0-41AD-B08E-893B58D49A5AQ55007708-A79BCB33-5620-4CF0-88BD-729017DA9E56Q55316446-2F257CB7-B010-46E0-8B40-9BDFB48A94A4Q55347685-7B8194C2-7E4A-4111-9D25-AB8259E28D3F
P2860
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
@ast
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
@en
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
@nl
type
label
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
@ast
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
@en
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
@nl
prefLabel
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
@ast
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
@en
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
@nl
P2093
P2860
P3181
P1433
P1476
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
@en
P2093
David Martin
Frank DeStefano
Michael Nguyen
Tom T Shimabukuro
P2860
P304
P3181
P356
10.1016/J.VACCINE.2015.07.035
P407
P577
2015-08-26T00:00:00Z